CLINICAL_TRIALS
trial_result
· 2023-12-12
Clinical Trial Update: Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study [Phase 2]
Summary
Phase 2 clinical trial update evaluating avelumab as frontline treatment for advanced classical Hodgkin lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN